Chemoinformaics analysis of (+)-Leucodelphinidin
| Molecular Weight | 322.269 | nRot | 1 |
| Heavy Atom Molecular Weight | 308.157 | nRig | 17 |
| Exact Molecular Weight | 322.069 | nRing | 3 |
| Solubility: LogS | -3.026 | nHRing | 1 |
| Solubility: LogP | -0.272 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 40.8011 |
| nHD | 7 | BPOL | 15.7809 |
| QED | 0.38 |
| Synth | 3.816 |
| Natural Product Likeliness | 2.321 |
| NR-PPAR-gamma | 0.803 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.005 |
| HIA | 0.473 |
| CACO-2 | -6.462 |
| MDCK | 0.00000381 |
| BBB | 0.033 |
| PPB | 0.897411 |
| VDSS | 0.622 |
| FU | 0.117375 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.078 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.082 |
| CYP2c9-sub | 0.525 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.092 |
| CL | 11.7 |
| T12 | 0.823 |
| hERG | 0.118 |
| Ames | 0.418 |
| ROA | 0.093 |
| SkinSen | 0.94 |
| Carcinogencity | 0.024 |
| EI | 0.67 |
| Respiratory | 0.05 |
| NR-Aromatase | 0.447 |
| Antiviral | Yes |
| Prediction | 0.825062 |